RxDoctor Payments Data

Samuel Grodofsky, MD

Anesthesiology · Bala Cynwyd, PANPI 1932426566

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,037 of the $10,301 with a category attached, or 87.7%. Abbott accounts for 62.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $2,845 and has fallen 86.1% since, to $395 in 2025. Among anesthesiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,301in general payments, 2019–2025

Across 361 payments — averaging $28.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Boston Scientific$2K
  • Vertos Medical, Inc.$943
  • Nevro Corp.$368
  • Medtronic$311
  • Painteq LLC$256
  • plus $352 from 5 others

What the payments were for

  • Travel & lodging$1,26412%
  • Food & beverage$9,03788%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,301 in reported general payments places this provider in the 95th percentile of 2,015 anesthesiology providers in Pennsylvania.

See all anesthesiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$82,772
Medicare patients
144
Services billed
832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5014$194,449
Oxycodone Hcl668$12,276
OxycontinOxycodone Hcl27$9,672
Fentanyl109$8,010
Morphine Sulfate ErMorphine Sulfate148$4,785
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen226$4,672
Diclofenac Potassium33$2,748
Gabapentin174$2,467
Morphine Sulfate87$2,429
Pregabalin103$2,078
Lidocaine14$2,046
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen73$1,501
Tizanidine Hcl120$1,393
Methadone Hcl85$1,138
Cyclobenzaprine Hcl85$853

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Bala Cynwyd

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →